← Back to Clinical Trials
Recruiting Phase 3 NCT06404177

Enantyum® IV Versus Piroxen® IM in Emergency Pain Management

Trial Parameters

Condition Traumatic Injury
Sponsor Riadh Boukef
Study Type INTERVENTIONAL
Phase Phase 3
Enrollment 300
Sex ALL
Min Age 18 Years
Max Age 85 Years
Start Date 2023-07-15
Completion 2024-08-01
Interventions
DexketoprofenPiroxicam

Brief Summary

For pain of traumatic origin, the RICE protocol (Rest, Ice, Compression, Elevation) is the main therapeutic measure during the first 4 to 5 days post-trauma. However, there is currently insufficient evidence that this protocol is effective \[4\]. In the emergency department, paracetamol, NSAIDs or a combination of several molecules are generally prescribed. Patients even use these drugs without a prescription. The aim of this study is to Compare the effect of dexketoprofen® IV versus piroxen® IM in the treatment of pain in emergency departments.

Eligibility Criteria

Inclusion Criteria: * Patients over 18 years of age who required analgesia for acute pain of traumatic origin and who signed a written consent form were included in the study. Exclusion Criteria: * Patients who meet the following conditions: * refusal, incapacity, difficulties with consent or communication * Patients with chronic pain. * Any known allergy or secondary reaction to piroxen or dexketoprofen trometamol. * Pregnant women. * Cirrhosis of the liver.

Related Trials